The Latest Breaking News on Pharma

Merck's profit guidance for 2023 widely missed Wall Street's projections on Thursday, leading Merck stock to crumble despite a quarterly beat.

Eli Lilly experienced a "bump in the road" for its newest diabetes treatment, Mounjaro, an analyst said Thursday as LLY stock toppled.

DC boss James Gunn has addressed a controversial tweet from Zachary Levi that called into question the "Shazam!" star's position on vaccines.

Emma Walmsley says ambition to be pharma superpower at risk unless improvements made in key areas

Rapidly growing market for personalized medicines and revolutionary technologies like 3D bioprinting is expected to bolster the biotech industry. Moreover, rising government initiatives should support its growth. Hence, quality biotech stocks Vertex Pharmaceuticals (VRTX), Biogen (BIIB), and Jazz Pharmaceuticals (JAZZ) might be ideal buys. Continue reading.

GSK stock and NVO stock rose Wednesday, though both beat forecasts. Novartis stock skidded on lighter-than-expected sales.

The Ministry of Public Health will press ahead with a controversial amendment that would make possession of more than one methamphetamine pill dealing in illegal narcotics.


A new law criminalising the possession, consumption and selling of cannabidiol (CBD) in Hong Kong came into effect on Wednesday, placing the substance on par with heroin in terms of legal classification.

Hong Kong banned cannibidiol, also known as CBD, as a "dangerous drug" and imposed harsh penalties for possession on Wednesday, forcing fledging businesses to shut down and revamp.